The company's revenue growth of 28 per cent to Rs 2,518 crore was ahead of consensus estimates
Election years have historically proved to be volatile, providing investors with intermittent investment opportunities
If the plan materialises, it will be the first Chinese exchange to conduct business in India
The stock hit a 52-week low of Rs 78.15, down 16 per cent, falling 30 per cent from its intra-day high of Rs 111 on the National Stock Exchange (NSE).
The S&P BSE Sensex lost 134 points or 0.37 per cent to settle at 36,445, with Sun Pharma (up 4.54 per cent) being the top gainer and Vedanta (down nearly 4 per cent) the worst laggard.
The move comes after its shares tumbled last week following reports about a complaint by a whistleblower to regulators relating to certain transactions involving the company and an executive director
The stock gained 6% to Rs 720, trading close to its all-time high level of Rs 729 touched September 3, 2018, in intra-day trade.
The maximum transaction limit for UPI payments is Rs 1 lakh. But an investor can apply for shares up to Rs 2 lakh in the retail category
The stock locked in lower circuit for the second straight day, down 20 per cent at Rs 21.25, its lowest level since August 1, 2013 on BSE.
Here are key technical levels you need to keep a tab on
Before heading into Tuesday's trade, investors are likely to take an account of the overnight developments in the global markets.
Nifty Metal index, the largest loser among sectoral indices, was down 2.55 per cent at 2,871 points, trading at its lowest level since June 27, 2017, on the NSE.
Unexpected change in insurance policy and rising fuel prices led to a lackluster festive season.
The stock was down 4.5% at Rs 86.55, trading at its lowest level since May 25, 2017, on the BSE.
The stock hit 52-week low of Rs 257, down 4 per cent on BSE, after the company reported 4 per cent year-on-year decline in net profit at Rs 2,211 crore in December quarter.
The drug major said that its domestic formulations distribution shall be transitioned from Aditya Medisales, the current distributor, to a wholly-owned subsidiary of Sun Pharma.
The short-term outlook for the market remains positive till Nifty trades above 10534 levels and expecting targets in the range of 11000-11300 levels
Here's a look at the top stocks that may remain in focus in today's session -
Most investors tend to panic the moment there is a correction in prices. Here are 10 things that investors must do when there is a 10 per cent correction
Nifty outlook and few trading ideas by Vaishali Parekh, research analyst- technical research at Prabhudas Lilladher.